Literature DB >> 30561370

Significant association among residual SYNTAX score, non-culprit major adverse cardiac events, and greyscale and virtual histology intravascular ultrasound findings: a substudy from the PROSPECT study.

Akiko Fujino1, Tadayuki Kadohira, Björn Redfors, Akiko Maehara, Patrick W Serruys, Gary S Mintz, Gregg W Stone, Philippe Généreux.   

Abstract

AIMS: Residual SYNTAX score (rSS) is known to be associated with cardiac events. We sought to investigate the association between rSS and greyscale and virtual histology (VH)-intravascular ultrasound (IVUS) plaque morphology, and the association between rSS and non-culprit-related major adverse cardiac events (MACE) using data from the PROSPECT study. METHODS AND
RESULTS: A total of 697 patients with acute coronary syndromes were enrolled in the PROSPECT study. Three-vessel greyscale and VH-IVUS were performed. Among them, 688 patients with paired baseline SS or SYNTAX score and rSS were identified and divided into three groups - rSS=0 (n=184), 0 <rSS ≤8 (n=364), and rSS >8 (n=140). MACE was defined as the composite of cardiac death, cardiac arrest, myocardial infarction, or rehospitalisation for unstable or progressive angina. There was a significant difference in the three-year non-culprit-related MACE rates among the three groups (5.7% versus 11.9% versus 19.7%, lowest to highest rSS; p=0.004) mainly due to rehospitalisation for unstable or progressive angina. On multivariable analysis, patients with ≥1 lesion with plaque burden ≥70% or ≥1 lesion with a minimum lumen area ≤4 mm2 and total dense calcium volume per patient were significantly correlated with rSS. Insulin-treated diabetes mellitus, rSS, and patients with ≥1 lesion with plaque burden ≥70% were independent predictors of non-culprit-related MACE.
CONCLUSIONS: Plaque morphology based on greyscale IVUS and VH-IVUS was significantly correlated with rSS, and rSS and plaque burden ≥70% independently predicted non-culprit-related MACE.

Entities:  

Mesh:

Year:  2019        PMID: 30561370     DOI: 10.4244/EIJ-D-18-00681

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome.

Authors:  Nuccia Morici; Gianfranco Alicandro; Luca A Ferri; Luigi Piatti; Daniele Grosseto; Paolo Sganzerla; Giovanni Tortorella; Maurizio Ferrario; Gabriele Crimi; Irene Bossi; Stefano Tondi; Anna Sonia Petronio; Matteo Mariani; Anna Toso; Amelia Ravera; Elena Corrada; Davide Cao; Leonardo Di Ascenzo; Carlo La Vecchia; Stefano De Servi; Stefano Savonitto
Journal:  CJC Open       Date:  2020-03-20

2.  Prognostic value of characteristics of plaque combined with residual syntax score among patients with STEMI undergoing primary PCI: an intravascular optical coherence tomography study.

Authors:  Xiaoxiao Zhao; Ying Wang; Runzhen Chen; Jiannan Li; Jinying Zhou; Chen Liu; Peng Zhou; Zhaoxue Sheng; Yi Chen; Li Song; Hanjun Zhao; Hongbing Yan
Journal:  Thromb J       Date:  2021-11-12

3.  Risk Stratification by Coronary Perfusion Pressure in Left Ventricular Systolic Dysfunction Patients Undergoing Revascularization: A Propensity Score Matching Analysis.

Authors:  Ming-Jer Hsieh; Chun-Chi Chen; Dong-Yi Chen; Cheng-Hung Lee; Ming-Yun Ho; Jih-Kai Yeh; Yu-Chang Huang; Yu-Ying Lu; Chieh-Yu Chang; Chao-Yung Wang; Shang-Hung Chang; I-Chang Hsieh
Journal:  Front Cardiovasc Med       Date:  2022-04-14

4.  Culprit-Plaque Morphology and Residual SYNTAX Score Predict Cardiovascular Risk in Acute Myocardial Infarction: An Optical Coherence Tomography Study.

Authors:  Ying Wang; Xiaoxiao Zhao; Peng Zhou; Chen Liu; Zhaoxue Sheng; Jiannan Li; Jinying Zhou; Runzhen Chen; Yi Chen; Li Song; Hanjun Zhao; Hongbing Yan
Journal:  J Atheroscler Thromb       Date:  2021-09-19       Impact factor: 4.394

5.  Objectifying the level of incomplete revascularization by residual SYNTAX score and evaluating the impact of incomplete revascularization on exercise tolerance in patients with coronary atherosclerotic heart disease treated by percutaneous coronary intervention.

Authors:  Lin Xue; Danjie Guo; Lan Wang; Chengfu Cao; Qi Li; Shangzhi Zou
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.